ARID1A GENE MUTATION
Clinical trials for ARID1A GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ARID1A GENE MUTATION trials appear
Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug cocktail aims to shrink Hard-to-Treat uterine cancers
Disease control Recruiting nowThis study tests whether combining two drugs—avelumab (an immunotherapy) and M1774 (a targeted pill)—can shrink or slow the growth of recurrent endometrial cancer in people whose tumors have a specific genetic change (ARID1A mutation). About 25 participants will receive the combi…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
New hope for advanced cancers? early trial of JAB-2485 begins
Disease control Recruiting nowThis study tests a new drug called JAB-2485 in about 100 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose, while also looking for signs that the drug shrinks tumors. The trial is in early …
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:02 UTC